Boosting our potential to improve the lives of people living with cancer, rare diseases and neurological conditions.


Ipsen has been around for almost one hundred years, and we intend to be around for another hundred. To accomplish this, we are building a high value, sustainable pipeline that covers every stage of development, from discovery to clinical research.

Key facts

As a mid-size pharma, we leverage our agility, R&D capabilities and global footprint to develop valuable business partnerships that fuel tomorrow’s breakthrough discoveries across our three therapeutic areas: Oncology, Rare Disease and Neuroscience. External innovation is at the heart of our strategy. We believe in the expertise of our partners and value the opportunity to collaborate, bringing our skills, experience and global reach to accelerate innovation to bring new medicines to patients.

Author Image

At Ipsen we believe great partnerships create great possibilities. These relationships are personal to us, and each asset is a priority for us, our teams and our executive team. It is extremely motivating to work through our alliances to translate…

EVP and Chief Business Officer


We are on a mission to deliver at least one new molecular entity or meaningful indication each year, so collaborations with other like-minded innovators are key for our continued growth. Our partners possess a shared energy to create meaningful differences with a sense of urgency and passion to drive programs forward. We collaborate with partners to define a shared vision to unlock the full potential of their assets, achieving mutual success for our partners and Ipsen.

Partnering events

Throughout the year, Ipsen holds numerous events for and with partners. Look through our upcoming events if you are interested in our work and in partnering with us and would like to meet our team.

Top stories in partnering

23 May 2023 2 mins read
Applications now open for the 2023 Golden Ticket Competition

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our Golden Ticket Competition is now open! Through our continued partnership with Biolabs, we’re delighted to be offering the brightest mi

12 August 2022 1 mins read
Epizyme welcome to Ipsen

Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.

14 October 2022 2 mins read
Ipsen becomes a founding sponsor of the second Biolabs innov

Ipsen announces that it becomes a founding sponsor of the second Biolabs innovation brain hub in Europe at Hopital Hotel Dieu, AP-HP, in Paris, France. The announcement builds on a 2018 commitment to a partnership with Biolabs for the development of a netw



Ipsen is committed to doing business responsibly. Generation Ipsen – For Positive Change unites all our employees behind a fully integrated approach built around four pillars: environment, patients, people and governance.